Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-05-21
1982-10-26
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3356, G01N 3358
Patent
active
043561640
ABSTRACT:
In the detection of the highly transmittable agent of non-A, non-B hepatitis there is described a method utilizing antigen-antibody reaction and a preferred counterelectrophoresis method for the detection of said antigen. The method may be applied as in the recipients of blood transfusions and also may be applied to screening blood donors where the blood donor had transmitted by transfusion non-A, non-B hepatitis antigen several years previously or there was at least a 1-5 year retrospective period from donating blood to retention of active transmittable agent.
REFERENCES:
patent: 3867517 (1975-02-01), Ling
Shirachi et al., The Lancet, Oct. 21, 1978, pp. 853-856.
Gocke et al., S. Immunology, vol. 104, Apr. 1970, pp. 1031-1032.
Tabor et al., Gastroenterology, 76:680-684, 1979.
Tabor et al., The Lancet, Mar. 4, 1978, pp. 463-466.
Tabor et al., From Viral Hepatitis, Ed. Vyas et al., Franklin Institute Press, Philadelphia, 1978, pp. 419-421.
Gerety Robert J.
Tabor Edward
Govt. of the U.S., as represented by the Secretary, Dept. of Hea
Nucker Christine M.
Roberts, Jr. John S.
LandOfFree
Detection of non-A, non-B hepatitis associated antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of non-A, non-B hepatitis associated antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of non-A, non-B hepatitis associated antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-947762